These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1746595)

  • 1. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors.
    Sultan Y; Kazatchkine MD; Nydegger U; Rossi F; Dietrich G; Algiman M
    Am J Med; 1991 Nov; 91(5A):35S-39S. PubMed ID: 1746595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
    Sultan Y; Rossi F; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):828-31. PubMed ID: 3101065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti idiotypic recognition of auto and allo antibodies to factor VIII by immunoglobulin preparations from single blood donors and large plasma pool.
    Sultan Y; Rossi F; Kazatchkine M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):539-43. PubMed ID: 1714857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiidiotypic suppression of autoantibodies with normal polyspecific immunoglobulins.
    Rossi F; Dietrich G; Kazatchkine MD
    Res Immunol; 1989 Jan; 140(1):19-31. PubMed ID: 2499021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of anti-idiotypic antibodies in a patient with a factor VIII autoantibody.
    Tiarks C; Pechet L; Humphreys RE
    Am J Hematol; 1989 Nov; 32(3):217-21. PubMed ID: 2510501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypes against autoantibodies to procoagulant factor VIII (VIII:C) in intravenous immunoglobulins.
    Kazatchkine MD; Rossi F; Sultan Y; Nydegger U
    Int Rev Immunol; 1989; 5(2):157-63. PubMed ID: 8691048
    [No Abstract]   [Full Text] [Related]  

  • 7. A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines and idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg).
    Dietrich G; Pereira P; Algiman M; Sultan Y; Kazatchkine MD
    J Autoimmun; 1990 Oct; 3(5):547-57. PubMed ID: 1701301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
    Dietrich G; Kaveri SV; Kazatchkine MD
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to factor VIII.
    Lacroix-Desmazes S; Misra N; Bayry J; Mohanty D; Kaveri SV; Kazatchkine MD
    Autoimmun Rev; 2002 Feb; 1(1-2):105-10. PubMed ID: 12849066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
    Dietrich G; Kazatchkine MD
    J Clin Invest; 1990 Mar; 85(3):620-5. PubMed ID: 2312717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to factor VIII inhibitors: the detection and quantitation.
    Kessler CM
    Am J Med; 1991 Nov; 91(5A):1S-5S. PubMed ID: 1746589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A; Brettschneider K; Kahle J; Orlowski A; Becker-Peters K; Stichel D; Schulze J; Braner M; Tampé R; Schwabe D; Königs C
    Thromb Haemost; 2016 Jul; 116(1):32-41. PubMed ID: 27009573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin.
    Nydegger UE; Sultan Y; Kazatchkine MD
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S72-82. PubMed ID: 2477188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals.
    Algiman M; Dietrich G; Nydegger UE; Boieldieu D; Sultan Y; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3795-9. PubMed ID: 1570298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
    Rossi F; Kazatchkine MD
    J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future approaches to factor VIII inhibitor therapy.
    Hoyer LW
    Am J Med; 1991 Nov; 91(5A):40S-44S. PubMed ID: 1746596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
    Sultan Y; Kazatchkine MD; Maisonneuve P; Nydegger UE
    Lancet; 1984 Oct; 2(8406):765-8. PubMed ID: 6148519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.